Stock Track | Immunome Inc. Soars 5.43% Intraday on Multiple Positive Analyst Actions

Stock Track
Mar 04

Immunome Inc. (IMNM) stock soared 5.43% during intraday trading on Wednesday, driven by a series of positive analyst actions and price target increases.

The rally followed several bullish research notes from major financial institutions. JPMorgan raised its price target on Immunome to $39 from $35 while maintaining an Overweight rating. Similarly, Craig-Hallum increased its target to $36 from $33 and reiterated a Buy rating on the shares. Stephens & Co. maintained its Overweight rating on the stock, while Piper Sandler continued to recommend the stock with a Buy rating and a $33 price target.

These analyst actions collectively contributed to positive investor sentiment, leading to the significant price appreciation during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10